PDE8A Activators
SEE ALSO...
Items 11 to 18 of 18 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Inhibits autophagy and lysosomal degradation, potentially affecting protein turnover related to SHISA8. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, a non-selective PDE inhibitor, may indirectly increase PDE8A activity by general inhibition of PDEs, potentially enhancing PDE8A’s role in specific cAMP degradation pathways. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil, a PDE5 inhibitor, can indirectly augment PDE8A activity by altering cGMP levels, potentially impacting cAMP dynamics under the regulatory scope of PDE8A. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, could impact signaling pathways, potentially affecting SHISA8. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast, a PDE5 inhibitor, may indirectly influence PDE8A activity by affecting cGMP and cAMP interplay, potentially enhancing PDE8A's role in cAMP metabolism. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, which might indirectly affect proteins involved in cell growth and survival. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Anagrelide, a PDE3 inhibitor, can indirectly enhance PDE8A activity by increasing cAMP levels due to reduced PDE3-mediated breakdown, potentially accentuating PDE8A's regulatory function. | ||||||
Papaverine | 58-74-2 | sc-279951 sc-279951A sc-279951B | 10 mg 50 mg 100 mg | $153.00 $265.00 $459.00 | ||
Papaverine, a non-selective PDE inhibitor, may indirectly enhance PDE8A activity by inhibiting various PDEs, potentially leading to a more significant role for PDE8A in cAMP regulation. | ||||||